Publication: Asian management of hypertension: Current status, home blood pressure, and specific concerns in Thailand
Issued Date
2020-01-01
Resource Type
ISSN
17517176
15246175
15246175
Other identifier(s)
2-s2.0-85079051748
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of Clinical Hypertension. (2020)
Suggested Citation
Peera Buranakitjaroen, Sirisawat Wanthong, Apichard Sukonthasarn Asian management of hypertension: Current status, home blood pressure, and specific concerns in Thailand. Journal of Clinical Hypertension. (2020). doi:10.1111/jch.13800 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/53847
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Asian management of hypertension: Current status, home blood pressure, and specific concerns in Thailand
Other Contributor(s)
Abstract
© 2020 Wiley Periodicals, Inc. The prevalence of hypertension is increasing, but rates of awareness, treatment, and blood pressure (BP) control are also increasing. In terms of cardiovascular disease, the prevalence of coronary artery disease (CAD) and stroke is similar, but stroke mortality is higher than that from CAD. Home BP monitoring (HBPM) is an important tool for determining the presence of white-coat or masked hypertension, facilitating drug cost savings or effective cardiovascular risk management strategies, respectively. However, there are a number of barriers to use of HBPM in Thailand. These include lack of availability (particularly in lower socioeconomic groups), lack of awareness of the importance of white-coat and masked hypertension, and concerns about device reliability. The latest Thai Hypertension Society guidelines recommend that physicians and nurses encourage their patients to use their HBPM devices, and these are increasingly being utilized in clinical practice for both diagnostic purposes and therapeutic monitoring. Calcium channel blockers are the most commonly used antihypertensive agents in Thailand, followed by angiotensin receptor blockers, ß-blockers, and diuretics. Angiotensin-converting enzyme inhibitors are used less often due to drug-related cough, and the use of fixed drug combinations is low because of their high cost and more complex reimbursement process. Ongoing work is needed to improve the primary prevention and effective treatment of hypertension in Thailand.